HJ
Herrmann John A III Executive Vice President, Chief Legal Officer and Corporate Secretary
C-suite M
Insider track record Executive Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Herrmann John A III, Executive Vice President, Chief Legal Officer and Corporate Secretary. Officer active across 1 company, notably NOVAVAX INC. Cumulatively, 25 filings have been logged. Split: 1 buy · 0 sell. History available since 30 April 2021. The latest transaction was filed on 10 March 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Herrmann John A III Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations 25 total
◇ EVP, Chief Legal Officer · Executives · 14 Dec 2023 · NOVAVAX INC 2,100 shares Common Stock SEC:0001209191-23-058988:0
◇ EVP, Chief Legal Officer · Executives · 25 Jun 2023 · NOVAVAX INC 833 shares Common Stock SEC:0001209191-23-039890:0
◇ EVP, Chief Legal Officer · Executives · 10 Mar 2023 · NOVAVAX INC 4,609 shares @ US$6.52 1.8% of flow Common Stock SEC:0001209191-23-018547:0
◇ EVP, Chief Legal Officer · Executives · 14 Dec 2022 · NOVAVAX INC 2,100 shares Common Stock SEC:0001209191-22-061705:0
◇ EVP, Chief Legal Officer · Executives · 26 Sept 2022 · NOVAVAX INC 3,973 shares Common Stock SEC:0001209191-22-051471:0
◇ EVP, Chief Legal Officer · Executives · 24 Aug 2022 · NOVAVAX INC 2,000 shares Common Stock SEC:0001209191-22-047756:0
◇ EVP, Chief Legal Officer · Executives · 25 Jun 2022 · NOVAVAX INC 833 shares Common Stock SEC:0001209191-22-039638:0
◇ EVP, Chief Legal Officer · Executives · 3 Jan 2022 · NOVAVAX INC 5,000 shares @ US$19.08 0.0056% mcap 5.3% of flow Common Stock SEC:0001209191-22-001815:0
◇ EVP, Chief Legal Officer · Executives · 20 Dec 2021 · NOVAVAX INC 5,000 shares @ US$19.08 0.0057% mcap 5.4% of flow Common Stock SEC:0001209191-21-070957:0
◇ EVP, Chief Legal Officer · Executives · 14 Dec 2021 · NOVAVAX INC 2,100 shares Common Stock SEC:0001209191-21-070017:0
◇ EVP, Chief Legal Officer · Executives · 1 Dec 2021 · NOVAVAX INC 5,000 shares @ US$19.08 10.4% of flow Common Stock SEC:0001209191-21-067969:0
◇ EVP, Chief Legal Officer · Executives · 29 Nov 2021 · NOVAVAX INC 5,000 shares @ US$19.08 10.4% of flow Common Stock SEC:0001209191-21-067292:0
◇ EVP, Chief Legal Officer · Executives · 3 Nov 2021 · NOVAVAX INC 5,000 shares @ US$19.08 10.1% of flow Common Stock SEC:0001209191-21-063205:0
◇ EVP, Chief Legal Officer · Executives · 1 Nov 2021 · NOVAVAX INC 5,000 shares @ US$19.08 10.2% of flow Common Stock SEC:0001209191-21-062725:0
◇ EVP, Chief Legal Officer · Executives · 1 Oct 2021 · NOVAVAX INC 5,000 shares @ US$19.08 10.1% of flow Common Stock SEC:0001209191-21-059543:0
◇ EVP, Chief Legal Officer · Executives · 26 Sept 2021 · NOVAVAX INC 3,973 shares Common Stock SEC:0001209191-21-057940:0
◇ EVP, Chief Legal Officer · Executives · 24 Aug 2021 · NOVAVAX INC 2,000 shares Common Stock SEC:0001209191-21-057656:0
◇ EVP, Chief Legal Officer · Executives · 15 Sept 2021 · NOVAVAX INC 5,000 shares @ US$19.08 9.9% of flow Common Stock SEC:0001209191-21-056676:0
◇ EVP, Chief Legal Officer · Executives · 1 Sept 2021 · NOVAVAX INC 5,000 shares @ US$19.08 9.9% of flow Common Stock SEC:0001209191-21-054817:0
◇ EVP, Chief Legal Officer · Executives · 26 Jul 2021 · NOVAVAX INC 417 shares @ US$27.60 1.2% of flow Common Stock SEC:0001209191-21-048440:0
◇ EVP, Chief Legal Officer · Executives · 30 Jun 2021 · NOVAVAX INC 416 shares @ US$27.60 1.2% of flow Common Stock SEC:0001209191-21-045060:0
◇ EVP, Chief Legal Officer · Executives · 25 Jun 2021 · NOVAVAX INC 834 shares Common Stock SEC:0001209191-21-043692:0
◇ EVP, Chief Legal Officer · Executives · 28 May 2021 · NOVAVAX INC 416 shares @ US$27.60 1.2% of flow Common Stock SEC:0001209191-21-037289:0
◇ EVP, Chief Legal Officer · Executives · 30 Apr 2021 · NOVAVAX INC 416 shares @ US$27.60 1.2% of flow Common Stock SEC:0001209191-21-030017:0
▲ SVP, General Counsel · Executives · 31 Jan 2016 · NOVAVAX INC 2,072 shares Common Stock SEC:0001209191-16-094491:0
Canonical exit: 30 Apr 2016 (T+90) About Herrmann John A III Herrmann John A III is Executive Vice President, Chief Legal Officer and Corporate Secretary. He has 25 filings in total, and the sampled recent filings relate to NOVAVAX INC, with transactions dated from 2016-02-01 to 2023-12-18. The total buy amount and total sell amount in the sampled recent filings are both 0, and the most frequent transaction nature is Levée d'options.